Literature DB >> 7427078

Hepatitis B vaccines.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7427078      PMCID： PMC1600089     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  J Skelly; J A Copeland; C R Howard; A J Zuckerman
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

2.  Hepatitis-B vaccine. Safety criteria and non-B infection.

Authors:  A J Zuckerman
Journal:  Lancet       Date:  1976-06-26       Impact factor: 79.321

3.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

4.  Analysis of hepatitis B surface antigen components solubilized with Triton X-100.

Authors:  J Skelly; C R Howard; A J Zuckerman
Journal:  J Gen Virol       Date:  1979-09       Impact factor: 3.891

5.  Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols.

Authors:  W Szmuness
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

6.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.